BEAT Overview

Aditxt Inc Stock Surge: Aditxt Inc's shares rose 63.4% to $2.32 in pre-market trading after filing a definitive proxy statement for a special stockholder meeting on January 30, 2026, regarding compliance with Nasdaq rules on share issuances.

Other Notable Gainers: Several stocks saw significant pre-market gains, including Agape ATP Corp (+66%), Direct Digital Holdings Inc (+35.3%), and DBV Technologies SA (+30.3%) following positive trial results.

Major Losers: Children's Place Inc experienced a sharp decline of 32.1% to $4.99 after disappointing third-quarter results, while other notable losers included AlphaVest Acquisition Corp (-19.8%) and Kyverna Therapeutics Inc (-19.2%).

Market Overview: The pre-market trading session showed a mix of gains and losses across various stocks, with some companies recovering from previous declines while others faced significant drops in share prices.

FDA Clearance: HeartBeam received FDA 510(k) clearance for its innovative cable-free 12-lead ECG technology, validating its 3D signal-capture approach and enabling clinical-grade arrhythmia assessments from a compact device.

Market Strategy: The company plans to launch its technology in early 2026 through concierge and preventive cardiology practices, aiming to validate real-world performance and refine its commercial model before broader scaling.

Long-term Growth Potential: The clearance opens opportunities for heart-attack detection and extended-wear monitoring, positioning HeartBeam for long-term growth and the development of AI-driven diagnostic tools using its ECG dataset.

Current Market Performance: Despite the regulatory milestone, HeartBeam's shares have declined 32.8% year-to-date, contrasting with industry growth, while the company maintains a Zacks Rank #3 (Hold).

Market Reaction to Fed Rate Cut: The stock market showed mixed results following the Federal Reserve's decision to cut interest rates by 25 basis points, reflecting a divide within the Fed on future policy directions amid a softer labor market and ongoing inflation concerns.

Top Performing Stocks: Notable stock movements included Oracle Corp, which saw a slight increase but dropped significantly in after-hours trading; Synopsys, which beat expectations and provided strong guidance; and HeartBeam, which surged after FDA clearance for its ECG technology.

Planet Labs' Strong Performance: Planet Labs reported a 33% increase in third-quarter revenue, exceeding expectations, and raised its full-year revenue outlook, leading to a significant after-hours stock spike.

Adobe's Earnings Report: Adobe's stock dipped slightly despite beating fourth-quarter expectations with earnings growth and strong subscription segment performance, while also providing optimistic fiscal 2026 guidance.

Stock Performance: HeartBeam, Inc. (NASDAQ: BEAT) saw a significant increase in stock price, rising 75.73% to $1.42, with a trading volume of 193.38 million shares compared to the average of 2.191 million.

FDA Clearance: The U.S. FDA granted 510(k) clearance for HeartBeam’s 12-lead ECG synthesis software, allowing patients to assess arrhythmias from home, with readings reviewed by board-certified cardiologists.

Growth Initiatives: HeartBeam plans a limited launch in early 2026 targeting concierge and preventive cardiology practices, aims to expand into heart attack detection, and is developing an extended-wear 12-lead ECG patch.

AI and Data Utilization: The company intends to leverage longitudinal data from its 3D ECG technology for AI-driven screening and predictive tools, enhancing capabilities beyond traditional ECG methods.